查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1868965

支氣管鏡切片檢查器械市場按技術、產品類型、應用、最終用戶和手術類型分類－2025-2032年全球預測

Bronchoscopic Biopsy Devices Market by Technology, Product Type, Application, End User, Procedure Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，支氣管鏡切片檢查設備市場規模將達到 14.1304 億美元，複合年成長率為 7.97%。

關鍵市場統計數據
基準年 2024 7.6465億美元
預計年份：2025年 8.2215億美元
預測年份 2032 1,413,040,000 美元
複合年成長率 (%) 7.97%

這篇清晰且有臨床依據的引言概述了支氣管切片檢查裝置的演變、臨床原理以及推動其在臨床實踐中應用的關鍵因素。

支氣管鏡切片檢查設備融合了肺科、腫瘤科和介入內視鏡技術，使臨床醫生能夠以越來越高的精度到達胸腔病灶，同時最大限度地減少患者併發症。近年來，影像、導航和設備小型化技術的進步，拓展了診斷範圍，使其延伸至肺部邊緣，並最佳化了縱膈評估。這催生了新的臨床工作流程，並促進了呼吸系統科醫生、胸腔外科醫生和介入放射科醫生之間的跨學科合作。在此背景下，從設備製造商到醫院採購團隊等相關人員，都需要一份清晰且有臨床依據的、關於不斷發展的技術格局、手術流程和應用促進因素的綜合分析，以指南其戰略制定。

本文簡要概述了由導航技術、去中心化和整合臨床工作流程驅動的、正在重塑支氣管鏡切片檢查格局的主要變革性轉變。

支氣管切片檢查器械領域正經歷變革性的轉變，這主要得益於技術融合、手術流程分散化以及臨床對微創診斷途徑日益成長的需求。導航技術將即時成像與電磁或虛擬引導相結合，拓展了支氣管鏡平台的應用範圍，使其能夠觸及以往主要透過經胸途徑才能到達的周邊肺組織。同時，內視鏡光學系統、器械通道設計和採樣儀器的改進提高了診斷產量並降低了併發症率。這增強了臨床醫師的信心，並改變了多學科腫瘤諮詢的轉診模式。

分析2025年美國生效的累積關稅如何影響支氣管鏡切片檢查設備的供應鏈、價格趨勢和採購方式

關稅調整和貿易政策行動會對醫療設備（包括支氣管鏡切片檢查平台和耗材）的供應鏈經濟、定價策略和採購決策產生重大影響。 2025年，美國實施了累積關稅調整，對某些類別的醫療設備進口加徵關稅，迫使製造商和經銷商重新評估籌資策略和服務成本模式。對於依賴跨國零件供應的公司而言，這些措施促使它們更加重視近岸外包、供應商整合以及與主要客戶重新談判商業條款，以維持利潤率和價格競爭力。

一種細緻入微、以細分主導的觀點，闡明了技術、產品架構、臨床應用、最終用戶畫像和流程目標如何影響產品的採用和價值獲取。

細分分析揭示了支氣管鏡切片檢查設備在以下幾個維度上的不同應用路徑和價值需求：核心技術、產品、應用領域、最終用戶和手術類型。在技​​術方面，臨床計畫評估了凸陣探頭EBUS、電磁導航和徑向EBUS平台在影像解析度、導航精度和手術便利性方面的優劣，每種模式都適用於不同的診斷應用情境和操作者經驗等級。產品類型的選擇受手術複雜性和醫療機構容量的影響。單通道設備因其高效的診斷流程而備受青睞，雙通道設備因其治療多樣性而備受青睞，而超細設備則適用於需要經皮路才能到達的遠端病灶。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 透過將即時機器人導航與電磁引導結合，實現精準的外周肺切片檢查。
  • 引入一次性支氣管切片檢查工具，以最大限度降低感染風險並簡化工作流程。
  • 人工智慧在支氣管鏡組織取樣現場組織病理學評估的應用
  • 可操控的軟性針狀導管的引入，使得精準到達難以觸及的肺部病灶成為可能。
  • 支氣管鏡系統中的擴展型切片檢查模組可以獲得更大的檢體，用於診斷瀰漫性肺部疾病。
  • 將超細支氣管鏡與先進的診斷影像設備結合，以提高周邊結節的取樣效率
  • 開發一種配備感測器的切片檢查鉗，用於即時組織回饋並提高手術安全性。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 按技術分類的支氣管鏡切片檢查設備市場

  • 凸陣探頭 EBUS
  • 電磁導航
  • 徑向 EBUS

9. 支氣管鏡切片檢查設備市場（依產品類型分類）

  • 雙通道設備
  • 單通道元件
  • 超薄設備

第10章 支氣管鏡切片檢查設備市場（按應用領域分類）

  • 中央病變的診斷
  • 縱膈病變的分期
    • 常規經支氣管抽吸切片檢查（TBNA）
    • EBUS引導下經支氣管吸取切片檢查
  • 周邊病變診斷
    • 無需導航的直接採樣
    • 電磁感應導航採樣
    • 虛擬支氣管鏡導航

第11章 支氣管鏡切片檢查設備市場（按最終用戶分類）

  • 門診手術中心
    • 公司所有權
    • 醫生所有
  • 醫院手術室
    • 私立醫院
    • 公立醫院
  • 專科癌症中心

第12章 支氣管鏡切片檢查器械市場（依手術類型分類）

  • 診斷性切片檢查
  • 治療性介入

第13章 支氣管鏡切片檢查器械市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 支氣管鏡切片檢查器械市場（按類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國支氣管鏡切片檢查器械市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Olympus Corporation
    • Boston Scientific Corporation
    • Medtronic plc
    • FUJIFILM Holdings Corporation
    • HOYA Corporation
    • KARL STORZ SE & Co. KG
    • Cook Medical LLC
    • Ambu A/S
    • Richard Wolf GmbH
    • CONMED Corporation
Product Code: MRR-C92ADB4B7664

The Bronchoscopic Biopsy Devices Market is projected to grow by USD 1,413.04 million at a CAGR of 7.97% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 764.65 million
Estimated Year [2025] USD 822.15 million
Forecast Year [2032] USD 1,413.04 million
CAGR (%) 7.97%

A clear and clinically grounded introduction that frames bronchoscopic biopsy device evolution, clinical rationale, and the operational drivers that shape adoption across healthcare settings

Bronchoscopic biopsy devices sit at the intersection of pulmonology, oncology, and interventional endoscopy, enabling clinicians to access thoracic lesions with increasing precision while minimizing patient morbidity. Recent advances in imaging, navigation, and device miniaturization have expanded diagnostic reach into peripheral lung territories and optimized mediastinal evaluation, creating new clinical workflows and cross-disciplinary collaboration between pulmonologists, thoracic surgeons, and interventional radiologists. Against this backdrop, stakeholders from device manufacturers to hospital procurement teams require a clear, clinically grounded synthesis of the evolving technology landscape, procedural pathways, and adoption enablers to inform strategy.

This introduction synthesizes the clinical rationale for bronchoscopic biopsy, highlights key device classes and their functional distinctions, and outlines the principal adoption drivers in contemporary practice. It also frames how reimbursement dynamics, procedure setting diversification, and clinician training intersect with technological evolution to shape deployment. By setting this context, readers will be positioned to understand downstream analyses of market forces, regulatory impacts, segmentation nuances, and recommended strategic responses that follow in the report.

A concise synthesis of the key transformative shifts reshaping the bronchoscopic biopsy device landscape driven by navigation, decentralization, and integrated clinical workflows

The landscape for bronchoscopic biopsy devices is undergoing transformative shifts driven by technological convergence, procedural decentralization, and heightened clinical demand for less invasive diagnostic pathways. Navigation technologies that integrate real-time imaging with electromagnetic or virtual guidance have extended the reach of bronchoscopic platforms into peripheral lung tissue previously accessible primarily by transthoracic approaches. Concurrent improvements in endoscope optics, tool channel engineering, and sampling instruments have improved diagnostic yield and reduced complication rates, which in turn have led to broader clinician confidence and evolving referral patterns within multidisciplinary tumor boards.

At the same time, the procedural setting is diversifying: ambulatory procedural centers and specialized cancer units are emerging as viable venues for selected bronchoscopic procedures, supported by streamlined sedation protocols and shorter recovery workflows. This shift is accompanied by growing interest in combined diagnostic and therapeutic pathways that pair biopsy with localized interventions or molecular sampling to inform precision oncology. Additionally, data and software are becoming central components of the value proposition; integration of navigation outputs with electronic health records and pathology workflows enhances longitudinal care coordination and supports value-based contracting. Taken together, these shifts are creating new imperatives for device makers, health systems, and clinical leaders to reassess product portfolios, training programs, and partnerships in order to capture evolving clinical pathways and institutional priorities.

An analysis of how the cumulative United States tariffs enacted in 2025 reverberated through supply chains, pricing dynamics, and procurement approaches for bronchoscopic biopsy devices

Tariff changes and trade policy actions can exert a material influence on the supply chain economics, pricing strategies, and procurement decisions for medical devices, including bronchoscopic biopsy platforms and consumables. In 2025, cumulative tariff adjustments enacted by the United States imposed added duties on select categories of medical device imports, prompting manufacturers and distributors to re-evaluate sourcing strategies and cost-to-serve models. For companies relying on cross-border component supply, these measures intensified focus on nearshoring, supplier consolidation, and renegotiation of commercial terms to maintain margin and competitive pricing in key accounts.

Operationally, healthcare providers experienced heightened procurement diligence as hospital purchasing teams and group purchasing organizations examined total landed costs, incorporating tariff-related price movements into capital planning and consumables budgeting. In response, several suppliers accelerated localization of assembly, increased inventory buffers at domestic distribution hubs, and introduced modular product configurations to reduce dependence on tariff-exposed subassemblies. From a strategic perspective, the tariffs catalyzed contractual innovations including longer-term price agreements, value-sharing models tied to outcomes, and expanded service offerings to preserve adoption momentum amid tighter budgetary constraints. Looking ahead, the cumulative effect of these measures underscores the need for manufacturers and health systems to maintain flexible supply networks, scenario-based pricing strategies, and transparent cost communication that align with institutional procurement policies and clinical imperatives.

A granular segmentation-driven perspective that clarifies how technology, product architecture, clinical application, end-user profiles, and procedure objectives shape adoption and value capture

Segmentation analysis reveals differentiated adoption pathways and value imperatives across the core technology, product, application, end user, and procedure type dimensions of bronchoscopic biopsy devices. Based on technology, clinical programs evaluate trade-offs among convex probe EBUS, electromagnetic navigation, and radial EBUS platforms in terms of imaging fidelity, navigation accuracy, and procedural ergonomics, with each modality aligning to distinct diagnostic use cases and operator expertise. Based on product type, device selection is influenced by procedural complexity and institutional throughput, with single channel devices preferred for streamlined diagnostic workflows, double channel devices valued for therapeutic versatility, and ultrathin devices enabling access to distal peripheral lesions that would otherwise require percutaneous approaches.

Based on application, clinical protocols and purchasing choices reflect the needs of central lesion diagnosis, mediastinal staging, and peripheral lesion diagnosis; within mediastinal staging clinicians further differentiate between conventional TBNA and EBUS-guided TBNA for procedural accuracy and sampling yield, while peripheral lesion diagnosis pathways bifurcate into direct sampling without navigation, electromagnetic navigated sampling, and virtual bronchoscopy navigation based on lesion location and institutional imaging capabilities. Based on end user, adoption dynamics are shaped by the operational profile of ambulatory surgical centers, hospital operating rooms, and specialized cancer centers, with ambulatory surgical centers further segmented into corporate owned and physician owned models, and hospital operating rooms divided between private and public hospital systems that have distinct procurement cycles, credentialing practices, and throughput expectations. Based on procedure type, device configurations and service bundles are tailored to whether the primary objective is diagnostic biopsy or therapeutic intervention, influencing consumable design, sterilization workflows, and perioperative support. By synthesizing these segmentation lenses, stakeholders can prioritize product development, training, and commercial strategies that are tightly aligned to the clinical, operational, and economic needs of target customer cohorts.

A regional insight framework that contrasts clinical adoption models, regulatory environments, and commercial execution priorities across the Americas, EMEA, and Asia-Pacific

Regional dynamics influence clinical practice patterns, regulatory pathways, and commercial approaches across the Americas, Europe Middle East & Africa, and Asia-Pacific, producing distinct opportunity sets and execution risks for bronchoscopic biopsy device stakeholders. In the Americas, established interventional pulmonology programs and integrated cancer centers support early adoption of advanced navigation and combined diagnostic-therapeutic procedures, while private payor models and large hospital networks drive emphasis on demonstrable procedural efficiency and bundled care pathways. Procurement cycles in this region often reward evidence of comparative clinical benefit, reimbursement alignment, and robust post-market surveillance.

Across Europe, the Middle East, and Africa, market heterogeneity is pronounced: western European centers prioritize guideline-driven adoption, health-technology assessments, and centralized purchasing, whereas emerging markets in the region may emphasize cost-effective solutions and partnerships that facilitate local training. Regulatory nuances and reimbursement fragmentation necessitate adaptive go-to-market strategies that balance clinical evidence generation with pragmatic distribution models. In the Asia-Pacific region, rapid expansion of cancer care infrastructure, rising access to advanced imaging, and pronounced interest in minimally invasive diagnostics accelerate demand for navigation-enabled platforms, yet suppliers must navigate diverse regulatory environments, variable procurement frameworks, and a spectrum of hospital capabilities. Collectively, these regional insights underscore the importance of tailored market entry plans, nuanced value propositions, and investment in clinician education to support sustainable uptake across geographies.

A competitive intelligence overview highlighting how incumbents, specialized innovators, and strategic partnerships are shaping product differentiation, clinical validation, and commercialization

Competitive dynamics across bronchoscopic biopsy devices are driven by a combination of legacy endoscopy manufacturers, specialized navigation providers, and ambitious medical technology startups that bring focused innovations in imaging, software, and consumable design. Incumbent firms typically leverage established clinical relationships, global service networks, and broad product portfolios to offer integrated solutions that address procedure efficiency and lifecycle support. Newer entrants and niche players often compete on the basis of targeted performance advantages-such as enhanced peripheral reach, streamlined user interfaces, or lower-cost disposables-that can displace legacy workflows in specialized programs.

Partnerships and distribution alliances are common strategic levers, particularly when firms seek rapid access to new geographies or complementary technology stacks. Licensing arrangements for navigation software, co-development partnerships with imaging providers, and joint training programs with academic centers are frequent pathways to accelerate clinical validation and adoption. Additionally, as hospitals and ambulatory centers increasingly evaluate total cost of ownership, companies that offer bundled service contracts, outcome-focused value propositions, and flexible financing will often find greater receptivity. For investors and corporate strategists, the competitive picture suggests an environment where product differentiation, evidence generation, and scalable commercial infrastructure determine the leaders of the next adoption cycle.

Actionable strategic recommendations for commercial, clinical, and supply chain leaders to accelerate adoption, secure value-based contracting, and reduce operational exposure

Industry leaders must pursue a balanced strategy that combines clinical evidence generation, supply chain resilience, and stakeholder-aligned commercial models to secure sustained adoption of bronchoscopic biopsy devices. First, prioritize prospective clinical studies and real-world evidence initiatives that demonstrate comparative safety and diagnostic performance across key applications such as mediastinal staging and peripheral lesion sampling; evidence tailored to reimbursement stakeholders will accelerate conversion in budget-constrained environments. Second, enhance supply chain flexibility through supplier diversification, regional assembly options, and inventory optimization to mitigate tariff and geopolitical exposure while preserving competitive pricing and service responsiveness.

Third, invest in comprehensive clinician training and credentialing programs that reduce procedural variability and increase repeatable outcomes; immersive simulation, proctoring networks, and integrated digital training tools can shorten the learning curve and increase institutional confidence. Fourth, design commercial bundles that reflect end-user economics-combining device hardware, consumables, software support, and outcome-linked service agreements-to align incentives with hospital and ambulatory center priorities. Finally, pursue selective partnerships with imaging providers, pathology networks, and IT integrators to create seamless clinical workflows that demonstrate measurable improvements in patient throughput, diagnostic timelines, and multidisciplinary decision-making. Executed together, these recommendations will position organizations to capture demand responsibly while reinforcing clinical value and operational scalability.

A transparent methodology blending clinician interviews, supplier consultations, literature review, and supply chain mapping to triangulate insights and validate practical applicability

The research methodology underpinning this analysis blended primary engagement with clinical and commercial stakeholders, systematic review of regulatory and clinical literature, and qualitative supply chain mapping to ensure a holistic understanding of the bronchoscopic biopsy device ecosystem. Primary inputs included in-depth interviews with interventional pulmonologists, thoracic surgeons, hospital procurement leaders, and biomedical engineering specialists, which illuminated real-world procedural workflows, device preferences, and training needs. These conversations were complemented by consultations with device developers and distribution partners to capture product roadmaps, commercialization challenges, and manufacturing considerations.

Secondary analysis incorporated peer-reviewed clinical studies, regulatory filings, procedural guidelines, and relevant industry reports to contextualize device performance, safety profiles, and adoption drivers. Supply chain and tariff impacts were assessed through import-export data, customs classifications, and documented corporate responses to trade measures, enabling scenario-based interpretation of operational risks. Throughout, findings were triangulated to validate themes and ensure consistency across data sources, with particular attention to clinical credibility and applicability for decision-makers in manufacturing, hospital leadership, and investment communities.

A concise conclusion synthesizing how clinical innovation, operational resilience, and evidence-driven commercialization collectively determine long-term value capture in bronchoscopic biopsy devices

In sum, bronchoscopic biopsy devices are converging toward greater clinical precision, procedural decentralization, and integrated data-enabled workflows that collectively expand their role in modern thoracic care. Technology differentiation-whether through navigation fidelity, ultrathin device engineering, or multi-channel versatility-will continue to determine clinical fit across central, mediastinal, and peripheral indications. Meanwhile, commercial success will hinge on credible clinical evidence, adaptable supply chains that withstand tariff and trade volatility, and commercial models that reflect the economics of diverse end users from ambulatory centers to large hospital systems.

As stakeholders prepare for the next phase of adoption, they should align product development with real-world procedural needs, invest in clinician competency programs, and pursue partnerships that enhance the end-to-end care pathway. Organizations that proactively address evidence generation, operational resilience, and customer-centric commercialization will be best positioned to capture long-term clinical and commercial value in this evolving landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of real-time robotic navigation with electromagnetic guidance for precise peripheral lung biopsies
  • 5.2. Adoption of single-use disposable bronchoscopic biopsy tools to minimize infection risks and streamline workflows
  • 5.3. Application of artificial intelligence for on-site histopathology assessment during bronchoscopic tissue sampling
  • 5.4. Implementation of steerable flexible needle catheters to access hard-to-reach pulmonary lesions with accuracy
  • 5.5. Expansion of cryobiopsy modules in bronchoscopic systems for obtaining larger samples in diffuse lung disease diagnosis
  • 5.6. Integration of ultrathin bronchoscopes with advanced imaging modalities to improve peripheral nodule sampling yields
  • 5.7. Development of sensor-enabled biopsy forceps providing real-time tissue feedback and enhanced procedural safety

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bronchoscopic Biopsy Devices Market, by Technology

  • 8.1. Convex Probe EBUS
  • 8.2. Electromagnetic Navigation
  • 8.3. Radial EBUS

9. Bronchoscopic Biopsy Devices Market, by Product Type

  • 9.1. Double Channel Devices
  • 9.2. Single Channel Devices
  • 9.3. Ultrathin Devices

10. Bronchoscopic Biopsy Devices Market, by Application

  • 10.1. Central Lesion Diagnosis
  • 10.2. Mediastinal Staging
    • 10.2.1. Conventional Tbna
    • 10.2.2. Ebus Guided Tbna
  • 10.3. Peripheral Lesion Diagnosis
    • 10.3.1. Direct Sampling Without Navigation
    • 10.3.2. Electromagnetic Navigated Sampling
    • 10.3.3. Virtual Bronchoscopy Navigation

11. Bronchoscopic Biopsy Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
    • 11.1.1. Corporate Owned
    • 11.1.2. Physician Owned
  • 11.2. Hospital Operating Rooms
    • 11.2.1. Private Hospitals
    • 11.2.2. Public Hospitals
  • 11.3. Specialized Cancer Centers

12. Bronchoscopic Biopsy Devices Market, by Procedure Type

  • 12.1. Diagnostic Biopsy
  • 12.2. Therapeutic Intervention

13. Bronchoscopic Biopsy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Bronchoscopic Biopsy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Bronchoscopic Biopsy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Olympus Corporation
    • 16.3.2. Boston Scientific Corporation
    • 16.3.3. Medtronic plc
    • 16.3.4. FUJIFILM Holdings Corporation
    • 16.3.5. HOYA Corporation
    • 16.3.6. KARL STORZ SE & Co. KG
    • 16.3.7. Cook Medical LLC
    • 16.3.8. Ambu A/S
    • 16.3.9. Richard Wolf GmbH
    • 16.3.10. CONMED Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRONCHOSCOPIC BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BRONCHOSCOPIC BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BRONCHOSCOPIC BIOPSY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVEX PROBE EBUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVEX PROBE EBUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVEX PROBE EBUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVEX PROBE EBUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVEX PROBE EBUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVEX PROBE EBUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY RADIAL EBUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY RADIAL EBUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY RADIAL EBUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY RADIAL EBUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY RADIAL EBUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY RADIAL EBUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DOUBLE CHANNEL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DOUBLE CHANNEL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DOUBLE CHANNEL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DOUBLE CHANNEL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DOUBLE CHANNEL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DOUBLE CHANNEL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SINGLE CHANNEL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SINGLE CHANNEL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SINGLE CHANNEL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SINGLE CHANNEL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SINGLE CHANNEL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SINGLE CHANNEL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ULTRATHIN DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ULTRATHIN DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ULTRATHIN DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ULTRATHIN DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ULTRATHIN DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ULTRATHIN DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CENTRAL LESION DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CENTRAL LESION DIAGNOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CENTRAL LESION DIAGNOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CENTRAL LESION DIAGNOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CENTRAL LESION DIAGNOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CENTRAL LESION DIAGNOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVENTIONAL TBNA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVENTIONAL TBNA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVENTIONAL TBNA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVENTIONAL TBNA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVENTIONAL TBNA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVENTIONAL TBNA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY EBUS GUIDED TBNA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY EBUS GUIDED TBNA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY EBUS GUIDED TBNA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY EBUS GUIDED TBNA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY EBUS GUIDED TBNA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY EBUS GUIDED TBNA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIRECT SAMPLING WITHOUT NAVIGATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIRECT SAMPLING WITHOUT NAVIGATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIRECT SAMPLING WITHOUT NAVIGATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIRECT SAMPLING WITHOUT NAVIGATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIRECT SAMPLING WITHOUT NAVIGATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIRECT SAMPLING WITHOUT NAVIGATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATED SAMPLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATED SAMPLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATED SAMPLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATED SAMPLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATED SAMPLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATED SAMPLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY VIRTUAL BRONCHOSCOPY NAVIGATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY VIRTUAL BRONCHOSCOPY NAVIGATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY VIRTUAL BRONCHOSCOPY NAVIGATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY VIRTUAL BRONCHOSCOPY NAVIGATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY VIRTUAL BRONCHOSCOPY NAVIGATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY VIRTUAL BRONCHOSCOPY NAVIGATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CORPORATE OWNED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CORPORATE OWNED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CORPORATE OWNED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CORPORATE OWNED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CORPORATE OWNED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CORPORATE OWNED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PHYSICIAN OWNED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PHYSICIAN OWNED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PHYSICIAN OWNED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PHYSICIAN OWNED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PHYSICIAN OWNED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PHYSICIAN OWNED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SPECIALIZED CANCER CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SPECIALIZED CANCER CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SPECIALIZED CANCER CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SPECIALIZED CANCER CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SPECIALIZED CANCER CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SPECIALIZED CANCER CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY THERAPEUTIC INTERVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY THERAPEUTIC INTERVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY THERAPEUTIC INTERVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY THERAPEUTIC INTERVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY THERAPEUTIC INTERVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY THERAPEUTIC INTERVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA BRONCHOSCOPIC BIOPSY DEVICE